Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$25.48 - $37.34 $30.9 Million - $45.3 Million
-1,212,595 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$32.46 - $43.42 $1.13 Million - $1.51 Million
34,721 Added 2.95%
1,212,595 $42.5 Million
Q1 2021

May 11, 2021

BUY
$38.94 - $50.85 $14.6 Million - $19.1 Million
376,019 Added 46.89%
1,177,874 $48 Million
Q4 2020

Feb 10, 2021

BUY
$37.65 - $63.77 $30.2 Million - $51.1 Million
801,855 New
801,855 $34.7 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.